Mankind Pharma to invest Rs 300 crore to set new unit
Pharmaceutical company Mankind Pharma is planning a dedicated factory in Udaipur. The firm would invest Rs 250 - Rs 300 crore in the Udaipur unit which is expected to begin operations by September-October this year. The unit will manufacture dydrogesterone key starting materials, active pharmaceutical ingredients (API), and formulations.
Also Read: New Drug Unit At Medak Planned By Hepa Lifesciences